Novartis
Global pharmaceutical company headquartered in Basel with major franchises in cardiovascular, immunology, and oncology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · C3G
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesPhase 3 · Recruiting · Acute Coronary Syndrome
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistaminesPhase 3 · Recruiting · Chronic Spontaneous Urticaria (CSU)
Study of Out of Specification for TisagenlecleucelPhase 3 · Recruiting · B-cell Acute Lymphoblastic Leukemia
An Extension Study for Patients Previously Enrolled in Studies With PelabresibPhase 3 · Recruiting · Hematologic Malignancy
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaPhase 3 · Recruiting · Asthma
Selected patent records
valsartan · Expires 2026-11-08
US 9388134*PEDvalsartan · Expires 2027-05-08
US 8877938valsartan · Expires 2027-05-27
US 8877938*PEDvalsartan · Expires 2027-11-27
US 8324225ribociclib succinate · Expires 2028-06-17
US 8324225*PEDribociclib succinate · Expires 2028-12-17
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/novartis/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.